From pre-submission to commercial launch, we help medical device companies build the commercial story and execution to reach the buyers, investors, and partners who matter.
Medical device commercialization requires its own playbook. Your regulatory pathway, 510(k), PMA, de novo, CE marking, shapes your commercial timeline and what you can say. Your buyers are surgeons, hospital administrators, procurement committees, and IDN executives, each with different motivations and different language. Your distribution model may involve GPOs, specialized distributors, or direct hospital relationships. The agencies that serve pharma don't understand device commercialization. The agencies that do devices often default to clinical evidence communication at the expense of market positioning and demand generation. HTG brings both, and we know what you can and can't claim at each stage of the regulatory process.
Commercialization positioning for investors and early partners. Pitch-ready messaging that explains the clinical and commercial case. Foundational assets: website, investor deck, technology brief. VC and partner targeting.
Go-to-market strategy. Sales enablement and channel development materials. KOL identification and engagement. Thought leadership programs for surgeon and clinical buyer audiences. Trade show strategy and event support: HIMSS, MDM West, DeviceTalks, and beyond. Lead generation for hospital and IDN buyers. Market intelligence and competitive analysis. Digital presence and discoverability. Technical content written at the clinical level.
Specialized execution for defined programs: a product launch in a new indication, a scientific conference, a market intelligence report, a KOL engagement program, sales team training. We are faster and more specialized than a generalist agency, and we integrate cleanly alongside your existing team.
Your science is ready.
Two paths in. Pick the one that fits.
